ICD10 code of Pseudomyxoma Peritonei and ICD9 code

Pseudomyxoma peritonei (PMP) does not have a single, dedicated code in the ICD-10 or ICD-9 systems because it is a clinical syndrome rather than a single disease entity; it is typically coded based on the underlying primary malignancy, most commonly using ICD-10 code C78.6 (Secondary malignant neoplasm of retroperitoneum and peritoneum) or ICD-9 code 158.8 (Other specified sites of peritoneum). Because Pseudomyxoma peritonei involves the accumulation of mucinous fluid in the abdominal cavity, accurate coding often requires coordination between your oncologist and medical coder to reflect both the PMP syndrome and the primary source of the mucin-producing tumor.

Why is coding for Pseudomyxoma peritonei complex?

The challenge in coding Pseudomyxoma peritonei lies in its classification. Historically, it was often classified as a tumor of the appendix, but it is now understood as a clinical presentation resulting from the rupture of mucinous neoplasms. When submitting claims for Pseudomyxoma peritonei, clinicians must often list the primary pathology (such as appendiceal adenocarcinoma) alongside the secondary peritoneal involvement to ensure appropriate insurance coverage and medical record accuracy.

How is the diagnosis of Pseudomyxoma peritonei typically confirmed?

Diagnosis of Pseudomyxoma peritonei is rarely based on a single test. Instead, it involves a combination of clinical, radiological, and pathological findings:

• Imaging: CT scans or MRIs showing "scalloping" of the liver or spleen caused by mucinous deposits.


• Pathology: Surgical biopsy is the gold standard to determine if the cells are low-grade or high-grade.


• Tumor Markers: Elevated levels of CEA, CA 19-9, and CA-125 are frequently tracked in patients with Pseudomyxoma peritonei.

What is the role of the medical community in managing this condition?

Living with a rare diagnosis can feel isolating, but you are not alone. Currently, 110 people with Pseudomyxoma peritonei have joined the DiseaseMaps community to share their experiences, surgical journeys, and coping strategies. Connecting with others who understand the nuances of Pseudomyxoma peritonei can provide essential emotional support and practical insights into navigating specialized care centers.

Next steps

• Consult with a surgical oncologist who specializes in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).


• Request a copy of your pathology report to ensure your primary tumor type is clearly identified for accurate medical coding.


• Join the Pseudomyxoma peritonei community at DiseaseMaps.org to connect with fellow patients and access peer-shared resources.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Pseudomyxoma peritonei


• Orphanet: Rare disease database (ORPHA:758)


• PMP Pals: Patient support and education for Pseudomyxoma peritonei


• World Health Organization (WHO) - ICD-10 Version: 2019 coding guidelines